Chang J, Wang H, Li J, Jin L
J Gastrointest Oncol. 2024; 15(2):710-720.
PMID: 38756643
PMC: 11094505.
DOI: 10.21037/jgo-23-992.
Ten Haaft B, Franssen S, van Dorst R, Rousian M, Pilz da Cunha G, de Wilde R
Ann Surg Oncol. 2024; 31(6):4022-4029.
PMID: 38498089
PMC: 11076355.
DOI: 10.1245/s10434-024-15127-w.
Feng A, Guo J, Gao S, Kou F, Liu S, Liu P
Front Oncol. 2022; 12:913017.
PMID: 36212504
PMC: 9532863.
DOI: 10.3389/fonc.2022.913017.
Kwan J, Pua U
Cancers (Basel). 2021; 13(6).
PMID: 33803606
PMC: 8003062.
DOI: 10.3390/cancers13061371.
Han S, Lee C, Im J, Kim J, Kim J, Kim S
Mol Ther Nucleic Acids. 2020; 23:154-168.
PMID: 33335800
PMC: 7732968.
DOI: 10.1016/j.omtn.2020.10.036.
Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy?.
Boerner T, Zambirinis C, Gagniere J, Chou J, Gonen M, Kemeny N
HPB (Oxford). 2020; 23(4):601-608.
PMID: 32943326
PMC: 8385642.
DOI: 10.1016/j.hpb.2020.08.018.
Role of yttrium-90 selective internal radiation therapy in the treatment of liver-dominant metastatic colorectal cancer: an evidence-based expert consensus algorithm.
Jeyarajah D, Doyle M, Espat N, Hansen P, Iannitti D, Kim J
J Gastrointest Oncol. 2020; 11(2):443-460.
PMID: 32399284
PMC: 7212103.
DOI: 10.21037/jgo.2020.01.09.
The impact of hepatic arterial infusion pump chemotherapy on hepatic recurrences and survival in patients with resected colorectal liver metastases.
Buisman F, Galjart B, van der Stok E, Kemeny N, Balachandran V, Boerner T
HPB (Oxford). 2020; 22(9):1271-1279.
PMID: 31889627
PMC: 7890567.
DOI: 10.1016/j.hpb.2019.11.013.
Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases: Results of a Safety and Feasibility Study in The Netherlands.
Buisman F, Grunhagen D, Homs M, Grootscholten C, Filipe W, Kemeny N
Ann Surg Oncol. 2019; 26(13):4599-4607.
PMID: 31641947
PMC: 6863781.
DOI: 10.1245/s10434-019-07973-w.
Comparative Efficacy of Preoperative, Postoperative, and Perioperative Treatments for Resectable Colorectal Liver Metastases: A Network Meta-Analysis.
Huang C, Huang J, Luo H, Zong Z, Zhu Z
Front Pharmacol. 2019; 10:1052.
PMID: 31619998
PMC: 6759603.
DOI: 10.3389/fphar.2019.01052.
Hepatic arterial chemotherapy with raltitrexed and oxaliplatin versus standard chemotherapy in unresectable liver metastases from colorectal cancer after conventional chemotherapy failure (HEARTO): a randomized phase-II study.
Ghiringhelli F, Vincent J, Bengrine L, Borg C, Jouve J, Loffroy R
J Cancer Res Clin Oncol. 2019; 145(9):2357-2363.
PMID: 31273511
DOI: 10.1007/s00432-019-02970-8.
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases - the multicenter randomized controlled PUMP trial.
Buisman F, Homs M, Grunhagen D, Filipe W, Bennink R, Besselink M
BMC Cancer. 2019; 19(1):327.
PMID: 30953467
PMC: 6451273.
DOI: 10.1186/s12885-019-5515-6.
Targeted codelivery of doxorubicin and IL-36γ expression plasmid for an optimal chemo-gene combination therapy against cancer lung metastasis.
Chen Y, Sun J, Huang Y, Liu Y, Liang L, Yang D
Nanomedicine. 2018; 15(1):129-141.
PMID: 30308300
PMC: 6289619.
DOI: 10.1016/j.nano.2018.09.005.
The development, commercialization, and clinical context of yttrium-90 radiolabeled resin and glass microspheres.
Westcott M, Coldwell D, Liu D, Zikria J
Adv Radiat Oncol. 2017; 1(4):351-364.
PMID: 28740906
PMC: 5514171.
DOI: 10.1016/j.adro.2016.08.003.
Perioperative Hepatic Arterial Infusion Pump Chemotherapy Is Associated With Longer Survival After Resection of Colorectal Liver Metastases: A Propensity Score Analysis.
Groot Koerkamp B, Sadot E, Kemeny N, Gonen M, Leal J, Allen P
J Clin Oncol. 2017; 35(17):1938-1944.
PMID: 28426374
PMC: 5466010.
DOI: 10.1200/JCO.2016.71.8346.
Updated long-term survival for patients with metastatic colorectal cancer treated with liver resection followed by hepatic arterial infusion and systemic chemotherapy.
Kemeny N, Chou J, Boucher T, Capanu M, DeMatteo R, Jarnagin W
J Surg Oncol. 2016; 113(5):477-84.
PMID: 26830685
PMC: 5076474.
DOI: 10.1002/jso.24189.
Colorectal hepatic metastasis: Evolving therapies.
Macedo F, Makarawo T
World J Hepatol. 2014; 6(7):453-63.
PMID: 25067997
PMC: 4110537.
DOI: 10.4254/wjh.v6.i7.453.
Models of hepatocellular carcinoma and biomarker strategy.
Bagi C, Andresen C
Cancers (Basel). 2013; 2(3):1441-52.
PMID: 24281167
PMC: 3837316.
DOI: 10.3390/cancers2031441.
Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
Abdalla E, Bauer T, Chun Y, DAngelica M, Kooby D, Jarnagin W
HPB (Oxford). 2013; 15(2):119-30.
PMID: 23297723
PMC: 3719918.
DOI: 10.1111/j.1477-2574.2012.00597.x.
Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer.
Sadahiro S, Suzuki T, Tanaka A, Okada K, Kamata H, Koisumi J
Surg Today. 2012; 43(10):1088-94.
PMID: 23143145
DOI: 10.1007/s00595-012-0416-1.
